Published in AJNR Am J Neuroradiol on June 19, 1991
Congenital frontonasal masses: developmental anatomy, malformations, and MR imaging. Pediatr Radiol (2006) 1.98
Developmental nasal midline masses in children: neuroradiological evaluation. Eur Radiol (2003) 0.95
Nasal chondromesenchymal hamartoma in young children: CT and MRI findings and review of the literature. World J Surg Oncol (2014) 0.88
Nasal obstruction in infancy. Arch Dis Child (1995) 0.80
Congenital midline nasofrontal masses. Pediatr Radiol (2012) 0.77
Subcutaneous neuroglial choristoma: an immunohistopathological case study. Br J Ophthalmol (1993) 0.75
Midline Craniofacial Masses in Children. Semin Plast Surg (2016) 0.75
Nasal Dermal Sinus Associated with a Dumbbell-Shaped Dermoid: A Case Report. J Neurol Surg Rep (2016) 0.75
Nasal glioma : A case report. Indian J Otolaryngol Head Neck Surg (2006) 0.75
Subcutaneous cavernous hemangioma in the nasal dorsum: report of case treated with endoscopic rhinoplasty. Int Arch Otorhinolaryngol (2013) 0.75
Nasofrontal dermoid with sinus tract upto the tip of the nose: A case report with review of the literature. Asian J Neurosurg (2016) 0.75
[Rare, but important differential diagnosis of masses at the fronto-etmoidal/naso-pharyngeal basis of the skull]. Radiologe (2016) 0.75
Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA (1998) 4.94
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J Exp Med (1980) 3.48
Continuous and discontinuous protein antigenic determinants. Nature (1986) 3.26
Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol (1982) 3.23
Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med (1988) 3.14
Location of 'continuous' antigenic determinants in the protruding regions of proteins. EMBO J (1986) 2.22
Immunogenicity of polysaccharides from type III, group B Streptococcus. J Clin Invest (1978) 1.95
Surgical treatment of syringomyelia. Favorable results with syringoperitoneal shunting. J Neurosurg (1984) 1.84
Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics (1981) 1.83
Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. Cancer Res (1997) 1.83
Skull base and calvarial deformities: association with intracranial changes in craniofacial syndromes. AJNR Am J Neuroradiol (1996) 1.81
Recurrent meningitis and Mondini dysplasia. Arch Otolaryngol Head Neck Surg (1990) 1.77
Revised classification of posterior fossa cysts and cystlike malformations based on the results of multiplanar MR imaging. AJR Am J Roentgenol (1989) 1.74
Schizencephaly: correlation of clinical findings with MR characteristics. AJNR Am J Neuroradiol (1992) 1.73
Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus. J Infect Dis (1979) 1.71
Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. J Neurosurg (1994) 1.68
Iron deficiency and glycosylated haemoglobin A. Lancet (1980) 1.62
Interventional neuroradiological management of vein of Galen malformations in the neonate. Neurosurgery (1990) 1.62
MR evaluation of spinal dermal sinus tracts in children. AJNR Am J Neuroradiol (1991) 1.61
Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination. J Pediatr (1979) 1.61
Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis. N Engl J Med (1987) 1.59
Difficulties in diagnosis of carcinoma of the breast in patients less than fifty years of age. Surg Gynecol Obstet (1993) 1.57
Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg (2001) 1.53
Progression of multiple cryptic vascular malformations associated with anomalous venous drainage. Case report. J Neurosurg (1994) 1.50
Long-term sequelae of group B streptococcal meningitis in infants. J Pediatr (1985) 1.49
Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus. J Clin Invest (1982) 1.47
Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol (1997) 1.47
The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy. Int J Radiat Oncol Biol Phys (1995) 1.45
Gamma knife radiosurgery in children. Pediatr Neurosurg (1996) 1.43
A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr Res (1987) 1.42
Quantitative determination of antibodies to type III group B streptococcal polysaccharide. J Infect Dis (1996) 1.41
A randomized clinical trial of daily nonstress testing versus biophysical profile in the management of preterm premature rupture of membranes. Am J Obstet Gynecol (1999) 1.39
Meningeal inflammation in neonatal gram-negative bacteremia. Pediatr Infect Dis J (1995) 1.38
Group B streptococcal conjugate vaccines. Arch Dis Child (2003) 1.32
Psoas abscess in children. Pediatr Infect Dis J (1990) 1.32
Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg (1996) 1.31
Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys (1989) 1.31
Nonlissencephalic cortical dysplasias: correlation of imaging findings with clinical deficits. AJNR Am J Neuroradiol (1992) 1.30
Nonoperative treatment of brain abscesses in selected high-risk patients. J Neurosurg (1980) 1.30
Intracranial arachnoid cysts in children. A comparison of the effects of fenestration and shunting. J Neurosurg (1991) 1.28
Outcome from severe head injury in children and adolescents. J Neurosurg (1985) 1.27
Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera. J Infect Dis (1980) 1.27
Neurocutaneous melanosis in association with the Dandy-Walker complex. Pediatr Dermatol (1992) 1.26
Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas. J Neurosurg (1986) 1.26
Intracranial arachnoid cysts in children. J Neurosurg (1986) 1.26
Role of complement receptors in opsonophagocytosis of group B streptococci by adult and neonatal neutrophils. J Infect Dis (1990) 1.24
Complications and sequelae of meningococcal infections in children. J Pediatr (1981) 1.23
Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma. Proc Natl Acad Sci U S A (1991) 1.23
Middle interhemispheric fusion: an unusual variant of holoprosencephaly. AJNR Am J Neuroradiol (1993) 1.23
Prospective diagnosis of early onset group B streptococcal infection by countercurrent immunoelectrophoresis. J Pediatr (1979) 1.22
Comparison of slide coagglutination test and countercurrent immunoelectrophoresis for detection of group B streptococcal antigen in cerebrospinal fluid from infants with meningitis. J Clin Microbiol (1980) 1.19
Treatment of giant intradural (perimedullary) arteriovenous fistulas. Neurosurgery (1993) 1.18
Aneurysms of the petrous portion of the internal carotid artery: results of treatment with endovascular or surgical occlusion. AJNR Am J Neuroradiol (1990) 1.16
An etiologic shift in infantile osteomyelitis: the emergence of the group B streptococcus. J Pediatr (1978) 1.15
Deposition and degradation of C3 on type III group B streptococci. Infect Immun (1991) 1.15
Contributions of complement and immunoglobulin to neutrophil-mediated killing of enterococci. Infect Immun (1992) 1.14
Transfemoral venous embolization of vein of Galen malformations. AJNR Am J Neuroradiol (1990) 1.13
In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling. J Neurosurg (1986) 1.12
Bilateral retinal hamartomas in neurofibromatosis type 2. Br J Ophthalmol (1991) 1.12
Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg (1991) 1.11
Iron therapy in patients on maintenance haemodialysis. Lancet (1970) 1.11
Gray matter heterotopias: MR characteristics and correlation with developmental and neurologic manifestations. Radiology (1992) 1.10
The role of complement and antibody in opsonophagocytosis of type II group B streptococci. J Infect Dis (1986) 1.10
Intracranial meningiomas of the first two decades of life. J Neurosurg (1994) 1.09
Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat Rep (1980) 1.09
Parenteral benzyl alcohol-induced hypersensitivity reaction. Drug Intell Clin Pharm (1986) 1.09
Radiation-induced telangiectasia in the brain simulates cryptic vascular malformations at MR imaging. Radiology (1994) 1.08
Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens. N Engl J Med (1980) 1.07
Can shoulder dystocia be predicted? Preconceptive and prenatal factors. J Reprod Med (1998) 1.07
Haematological changes in a patient on long-term treatment with a trimethoprim-sulphonamide combination. Postgrad Med J (1970) 1.07
Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents. J Clin Endocrinol Metab (1997) 1.06
Countercurrent immunoelectrophoresis in the evaluation of infants with group B streptococcal disease. Pediatrics (1980) 1.06
Radiation therapy for primary intracranial germ-cell tumors. Int J Radiat Oncol Biol Phys (1995) 1.06
An evaluation of the in utero neurosurgical treatment of ventriculomegaly. Clin Neurosurg (1986) 1.06
Hepatitis and epidemic hepatitis associated antigen (E.H.A.A.) in a haemodialysis unit with observations on haemoglobin levels. Br J Urol (1972) 1.06
Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources. J Neurosurg (1987) 1.05
The laser in neurological surgery. J Neurosurg (1983) 1.05
Group B streptococcal infections. Perinatal impact and prevention methods. Ann N Y Acad Sci (1988) 1.04
Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics (1994) 1.03
Clinical indicators of childhood retropharyngeal abscess. Am J Emerg Med (1995) 1.02
Intramedullary neurilemomas of the spinal cord: report of two cases and review of the literature. Neurosurgery (1986) 1.02
Prevalence of antibody to Trypanosoma cruzi in pregnant Hispanic women in Houston. Clin Infect Dis (1999) 1.01
Comparison of the brain tissue response in rats to injury by argon and carbon dioxide lasers. Neurosurgery (1982) 1.00
Kaolin-induced congenital hydrocephalus in utero in fetal lambs and rhesus monkeys. J Neurosurg (1984) 1.00
Long-term benefits of early neurosurgery for lipomyelomeningocele. J Urol (1998) 0.99
Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci. Infect Immun (1996) 0.99
Pelvic osteomyelitis in children. Pediatrics (1978) 0.99
Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Hum Genet (1992) 0.99
Analysis, design and modification of loop regions in proteins. Bioessays (1988) 0.99
Subdural empyema: an unusual complication of meningococcal meningitis. South Med J (1982) 0.98
Computerized tomography of cranial sutures. Part 2: Abnormalities of sutures and skull deformity in craniosynostosis. J Neurosurg (1984) 0.98
Radiotherapy of primary intracranial germinomas: the case against routine craniospinal irradiation. Int J Radiat Oncol Biol Phys (1988) 0.98
Craniosynostosis and hydrocephalus. Neurosurgery (1987) 0.97
Deletion mapping of the medulloblastoma locus on chromosome 17p. Genomics (1990) 0.97
Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes. Mol Genet Metab (2001) 0.97
Treatment results of juvenile pilocytic astrocytoma. J Neurosurg (1988) 0.97